Sunday 26 July 2026
⬤ Company results

#startup of the day 6 - Scanbo India Private Limited

Scaling AI diagnostics with ethical innovation

By BioSpectrum Bureau Published on: 11th July, 2026
#startup of the day 6 - Scanbo India Private Limited

Inception - 2021

Location -  India operations, with global headquarters in Canada, Operation in USA. Manufacturing and R&D based in Surat, Gujarat.

Industry domain -  Healthcare AI / Point-of-Care Diagnostics / MedTech

Founder - Ashissh Raichura, Founder & CEO

Total team strength - 35

Total funds raised - Undisclosed 

Investors - Undisclosed at the stage

Revenue generated since inception - Undisclosed. The company is revenue-generating across multiple markets, with paid deployments across hundreds of clinical settings.

Key Highlights - 

  1. CDSCO approval received in India for the Scanbo D8 multi-parameter diagnostic device and HridayTaal cardiac AI agent.
  2. Over one million AI analyses completed through the HridayTaal cardiac agent in real clinical environments.
  3. Deployed across hundreds of clinical settings, from urban hospitals to primary care in remote geographies.
  4. Certifications held: ISO 13485, MDSAP, ISO 27001, HIPAA, SOC2, GDPR — aligning Scanbo to global healthcare quality, security, and privacy standards.
  5. Own manufacturing facility built to global standards in Surat, Gujarat, under a Make in India strategy for global markets.
  6. US FDA clearance process now underway for international expansion.
  7. Founder Ashissh Raichura advanced to Round 2 of TEDx Southlake 2026 speaker selection.
  8. Founder authored the “Dignity over Dependency” manifesto (dignityoverdependency.org), articulating an ethical AI framework for healthcare adopted as Scanbo’s guiding design principle.

Founder Speaks - 

Scanbo is focused on scaling its AI-powered point-of-care diagnostic platform to reach more patients and clinicians across India and globally. Immediate priorities include continued deployment expansion across Indian healthcare settings, pursuing US FDA clearance to unlock international markets, and advancing its portfolio of clinical AI agents. Over the longer term, Scanbo will continue building around its Dignity over Dependency framework — the principle that AI in healthcare should make clinicians and patients more capable rather than more dependent — as both a product design foundation and a broader public conversation on ethical AI in healthcare.

Ashissh Raichura, Founder & CEO

Published on: 11th July, 2026